Global Hemostatic Agents in Endoscopy Market Growth (Status and Outlook) 2026-2032
The global Hemostatic Agents in Endoscopy market size is predicted to grow from US$ 157 million in 2025 to US$ 365 million in 2032; it is expected to grow at a CAGR of 12.8% from 2026 to 2032.
Hemostatic Agents in Endoscopy refers to topical or locally delivered hemostatic materials designed for gastrointestinal endoscopic procedures to control active bleeding, support post-procedural hemostasis, and provide protective coverage over mucosal defects. These products are delivered through an endoscope in the form of powders, hydrogels, sprays, adhesive barriers, or other absorbable formulations and achieve hemostasis through mechanisms such as rapid fluid absorption, concentration of platelets and coagulation factors, formation of a mechanical barrier, moisture-activated adhesion, or self-assembling hydrogel formation. Key product characteristics include speed of initial hemostasis, coverage of broad or irregular bleeding surfaces, adhesion and persistence in wet gastrointestinal environments, catheter deliverability, visualization during treatment, biocompatibility, rebleeding performance, and compatibility with standard endoscopic workflows. Hemostatic Agents in Endoscopy are used in gastrointestinal bleeding management and therapeutic procedures including endoscopic mucosal resection, endoscopic submucosal dissection, polypectomy, tumor-related bleeding, ulcer bleeding, and other situations requiring rapid topical control of bleeding. This research focuses on finished endoscopically delivered hemostatic agents and evaluates the market by product technology, clinical application, regional demand, industry chain, sales channels, and competitive structure.
ESD represented approximately 61.9% of global Hemostatic Agents in Endoscopy revenue by application in 2025
The five leading manufacturers collectively accounted for approximately 95.9% of global market revenue in 2025
North America represented approximately 36.6% of global revenue in 2025 while Asia-Pacific showed a comparable market scale
Non-contact powders and hydrogels are becoming increasingly important in complex gastrointestinal bleeding management
The midstream stage includes formulation, peptide or polymer processing, particle engineering, aseptic or powder filling, sterilization, packaging, catheter integration, quality inspection and final product release. Value creation is concentrated in proprietary material technology and the ability to translate that technology into predictable hemostasis, tissue adherence, catheter compatibility and clinical usability. Downstream customers consist mainly of hospitals, gastroenterology departments, ambulatory surgical centers and specialist endoscopy clinics. Large hospitals and healthcare groups commonly purchase through direct contracts, tenders or group purchasing organizations, while regional distributors remain important in geographically fragmented markets. Profitability therefore depends on formulation differentiation, manufacturing quality, regulatory approvals, clinical evidence, procedural convenience and access to endoscopy sales channels.
By application, ESD represented approximately 61.9% of global revenue in 2025, compared with approximately one-quarter for EMR, while other gastrointestinal bleeding applications accounted for the remainder. ESD has particularly strong demand for topical hemostatic technologies because the procedure creates large artificial ulcers and exposes multiple submucosal vessels, increasing the need for intraoperative bleeding control and broad post-resection coverage. Continued expansion of advanced resection procedures is therefore likely to increase the strategic importance of products optimized for prolonged procedures, large treatment areas and delayed-bleeding management.
Asia-Pacific represented a market scale close to North America in 2025 and is becoming increasingly important as therapeutic endoscopy capacity expands. East Asian markets have particularly strong experience with EMR and ESD, supporting demand for products suited to large resection beds and prolonged procedures, while China and other developing Asian markets continue to expand hospital endoscopy capacity and physician training. Latin America and the Middle East & Africa remain smaller markets but offer longer-term opportunities as advanced gastrointestinal endoscopy becomes more accessible, although reimbursement, regulatory approval and distribution coverage continue to create significant regional differences.
This Insight Report provides a comprehensive analysis of the global Hemostatic Agents in Endoscopy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hemostatic Agents in Endoscopy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemostatic Agents in Endoscopy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemostatic Agents in Endoscopy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemostatic Agents in Endoscopy.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostatic Agents in Endoscopy market by product type, application, key players and key regions and countries.
Hemostatic Agents in Endoscopy refers to topical or locally delivered hemostatic materials designed for gastrointestinal endoscopic procedures to control active bleeding, support post-procedural hemostasis, and provide protective coverage over mucosal defects. These products are delivered through an endoscope in the form of powders, hydrogels, sprays, adhesive barriers, or other absorbable formulations and achieve hemostasis through mechanisms such as rapid fluid absorption, concentration of platelets and coagulation factors, formation of a mechanical barrier, moisture-activated adhesion, or self-assembling hydrogel formation. Key product characteristics include speed of initial hemostasis, coverage of broad or irregular bleeding surfaces, adhesion and persistence in wet gastrointestinal environments, catheter deliverability, visualization during treatment, biocompatibility, rebleeding performance, and compatibility with standard endoscopic workflows. Hemostatic Agents in Endoscopy are used in gastrointestinal bleeding management and therapeutic procedures including endoscopic mucosal resection, endoscopic submucosal dissection, polypectomy, tumor-related bleeding, ulcer bleeding, and other situations requiring rapid topical control of bleeding. This research focuses on finished endoscopically delivered hemostatic agents and evaluates the market by product technology, clinical application, regional demand, industry chain, sales channels, and competitive structure.
Key Findings
Mineral Hemostatic Powder accounted for approximately 53.8% of global Hemostatic Agents in Endoscopy revenue in 2025ESD represented approximately 61.9% of global Hemostatic Agents in Endoscopy revenue by application in 2025
The five leading manufacturers collectively accounted for approximately 95.9% of global market revenue in 2025
North America represented approximately 36.6% of global revenue in 2025 while Asia-Pacific showed a comparable market scale
Non-contact powders and hydrogels are becoming increasingly important in complex gastrointestinal bleeding management
Market Trends
The Hemostatic Agents in Endoscopy market is moving toward non-contact, broad-coverage and easier-to-deploy technologies that can rapidly control diffuse or technically difficult bleeding without requiring precise mechanical targeting. Mineral and polysaccharide powders continue to serve large bleeding surfaces efficiently, while adhesive polymer systems and self-assembling peptide hydrogels are expanding the range of available mechanisms and clinical use scenarios. Product development is increasingly focused on stronger tissue adhesion, longer residence time, resistance to wash-off in wet gastrointestinal environments, reduced catheter blockage, improved spray or gel delivery, and preservation of visualization during treatment. Another important trend is the growing use of topical hemostatic agents around EMR and ESD procedures, where large mucosal defects and multiple potential bleeding points create demand for solutions that provide broad wound coverage and may support management of immediate and delayed bleeding. As the market matures, differentiation is shifting from initial hemostasis alone toward rebleeding control, procedural efficiency, delivery reliability, clinical evidence, and integration with multimodal endoscopic treatment.Market Dynamics
Drivers
Growth of the Hemostatic Agents in Endoscopy market is primarily driven by increasing volumes of therapeutic gastrointestinal endoscopy, broader use of EMR and ESD, and continued demand for minimally invasive management of gastrointestinal bleeding. Conventional clipping, thermal coagulation and injection techniques can be technically challenging in diffuse bleeding, large lesions, friable tumors or anatomically difficult locations, creating a clear role for topical agents capable of covering a wider treatment surface. Expansion of specialized gastroenterology centers, improvements in endoscopic equipment and physician training, and greater detection of gastrointestinal lesions further enlarge the addressable procedure base. The disposable nature of most delivery systems also supports recurring demand directly linked to procedure volumes.Restraints
Market development is constrained by the relatively high procedure-level cost of specialized hemostatic agents compared with conventional endoscopic techniques, particularly in healthcare systems without dedicated reimbursement. Some products provide rapid initial hemostasis but may form temporary barriers that can detach or degrade, creating the possibility of rebleeding and requiring subsequent clipping, thermal treatment, angiographic intervention or surgery in high-risk cases. Technical limitations such as catheter blockage, uneven powder dispersion, reduced performance after premature contact with blood or moisture, and temporary obscuration of the endoscopic field can also affect physician adoption. Differences in regulatory approval, reimbursement and hospital purchasing policies further limit uniform market penetration.Opportunities
Important opportunities are emerging from the expansion of complex EMR, ESD and other advanced therapeutic endoscopy procedures, particularly in markets where these techniques are still increasing in penetration. Products that combine rapid hemostasis with reliable adhesion, broad surface coverage, good visualization and longer persistence can address unmet needs associated with large resection beds and difficult-to-access bleeding sites. Development of transparent gels, improved absorbable powders, moisture-activated adhesive systems and more reliable delivery catheters can further broaden clinical utility. Geographic expansion through partnerships with established endoscopy companies and regional distributors also creates opportunities to improve access in developing healthcare markets where advanced gastrointestinal endoscopy capacity is expanding.Challenges
The principal industry challenge is achieving consistent clinical effectiveness across different bleeding severities, lesion types, anatomical locations and operator techniques. A product that performs well in diffuse oozing may not be sufficient as definitive monotherapy for severe arterial bleeding, meaning that clinical positioning must often account for adjunctive, rescue or bridge use. Manufacturers also face the challenge of demonstrating reductions in rebleeding, repeat intervention and overall treatment cost through sufficiently robust clinical evidence. At the same time, they must maintain reliable powder propulsion or gel delivery, prevent catheter blockage, ensure biocompatibility and sterility, and meet different regulatory requirements across international markets. These factors raise development costs and lengthen commercialization cycles.Industry Chain Analysis
The upstream segment of the Hemostatic Agents in Endoscopy industry includes functional hemostatic materials such as mineral absorbents, absorbable polysaccharides, synthetic polymers and self-assembling peptides, together with pharmaceutical-grade water, buffers, stabilizers, viscosity modifiers and other formulation inputs. Packaging and delivery components, including syringes, powder cartridges, applicators, endoscopic catheters, connectors and sterile barrier packaging, are also critical because product performance depends not only on the active material but on reliable delivery through the endoscope. Raw-material purity, particle-size distribution, polymer consistency, peptide purity, endotoxin control and sterilization compatibility directly influence clinical performance and manufacturing quality.The midstream stage includes formulation, peptide or polymer processing, particle engineering, aseptic or powder filling, sterilization, packaging, catheter integration, quality inspection and final product release. Value creation is concentrated in proprietary material technology and the ability to translate that technology into predictable hemostasis, tissue adherence, catheter compatibility and clinical usability. Downstream customers consist mainly of hospitals, gastroenterology departments, ambulatory surgical centers and specialist endoscopy clinics. Large hospitals and healthcare groups commonly purchase through direct contracts, tenders or group purchasing organizations, while regional distributors remain important in geographically fragmented markets. Profitability therefore depends on formulation differentiation, manufacturing quality, regulatory approvals, clinical evidence, procedural convenience and access to endoscopy sales channels.
Segment Insights
By product technology, Mineral Hemostatic Powder represented approximately 53.8% of global Hemostatic Agents in Endoscopy revenue in 2025 and remained the largest segment, reflecting its established use for rapid non-contact coverage of active gastrointestinal bleeding. Peptide Hydrogels accounted for a smaller share but showed a structurally different value proposition based on transparent application, localized physical barrier formation and suitability for advanced therapeutic endoscopy. The remaining market includes polysaccharide-based powders and adhesive polymer systems, which compete through absorbability, moisture interaction, tissue adherence and delivery characteristics. The segment structure therefore reflects multiple complementary hemostatic mechanisms rather than a single standardized technology.By application, ESD represented approximately 61.9% of global revenue in 2025, compared with approximately one-quarter for EMR, while other gastrointestinal bleeding applications accounted for the remainder. ESD has particularly strong demand for topical hemostatic technologies because the procedure creates large artificial ulcers and exposes multiple submucosal vessels, increasing the need for intraoperative bleeding control and broad post-resection coverage. Continued expansion of advanced resection procedures is therefore likely to increase the strategic importance of products optimized for prolonged procedures, large treatment areas and delayed-bleeding management.
Downstream Market Opportunities
The most attractive downstream opportunities for Hemostatic Agents in Endoscopy are concentrated in high-volume hospitals and specialist endoscopy centers performing advanced gastrointestinal interventions. These customers increasingly value products that can rapidly cover diffuse bleeding, reduce time spent targeting multiple individual bleeding points, maintain endoscopic visualization, and integrate easily with existing catheters and therapeutic workflows. Growth of EMR, ESD and complex polypectomy expands demand for products capable of treating large mucosal defects, while outpatient migration of selected endoscopic procedures creates additional opportunities for ready-to-use systems with simple preparation and predictable performance. Manufacturers that can demonstrate clinical efficiency, lower rebleeding risk, reliable delivery and favorable procedure-level economics are better positioned to increase downstream adoption.Regional Insights
North America represented approximately 36.6% of global Hemostatic Agents in Endoscopy revenue in 2025 and remains an important commercial market due to developed gastrointestinal endoscopy infrastructure, high treatment expenditure and broad access to advanced endoscopic technologies. Europe also maintains a substantial market supported by established gastroenterology services and increasing use of therapeutic endoscopy. In these mature regions, adoption is influenced not only by initial hemostatic effectiveness but also by clinical evidence, reimbursement conditions, physician familiarity, product availability and total treatment economics.Asia-Pacific represented a market scale close to North America in 2025 and is becoming increasingly important as therapeutic endoscopy capacity expands. East Asian markets have particularly strong experience with EMR and ESD, supporting demand for products suited to large resection beds and prolonged procedures, while China and other developing Asian markets continue to expand hospital endoscopy capacity and physician training. Latin America and the Middle East & Africa remain smaller markets but offer longer-term opportunities as advanced gastrointestinal endoscopy becomes more accessible, although reimbursement, regulatory approval and distribution coverage continue to create significant regional differences.
Competitive Landscape Analysis
The Hemostatic Agents in Endoscopy market is highly concentrated, with the five leading manufacturers accounting for approximately 95.9% of global revenue in 2025. Competition is differentiated by hemostatic mechanism and technology platform: established mineral powders compete through rapid non-contact coverage and broad clinical familiarity; self-assembling peptide hydrogels emphasize transparency, localized barrier formation and compatibility with advanced resection procedures; absorbable polysaccharide powders focus on fluid absorption and concentration of coagulation components; and adhesive polymer systems compete through moisture-activated tissue adherence. Leading participants such as Cook Medical, 3-D Matrix, EndoClot Plus, Next Biomedical and BioCer Entwicklungs therefore occupy different technology positions rather than offering completely interchangeable products. Competitive advantage increasingly depends on clinical evidence, rebleeding performance, catheter reliability, regulatory approvals, physician education, international distribution and the ability to demonstrate procedural value beyond initial bleeding control.Report Scope
LPI (LP Information)' newest research report, the “Hemostatic Agents in Endoscopy Industry Forecast” looks at past sales and reviews total world Hemostatic Agents in Endoscopy sales in 2025, providing a comprehensive analysis by region and market sector of projected Hemostatic Agents in Endoscopy sales for 2026 through 2032. With Hemostatic Agents in Endoscopy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemostatic Agents in Endoscopy industry.This Insight Report provides a comprehensive analysis of the global Hemostatic Agents in Endoscopy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hemostatic Agents in Endoscopy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemostatic Agents in Endoscopy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemostatic Agents in Endoscopy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemostatic Agents in Endoscopy.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostatic Agents in Endoscopy market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Type:
- Peptide Hydrogels
- Mineral Hemostatic Powder
- Other
Segmentation by Product:
- Self-assembling Type
- Spray Type
- Other
Segmentation by Biodegradability:
- Absorbable / Biodegradable Agents
- Temporary Non-Absorptive Barrier Systems
Segmentation by Application:
- ESD
- EMR
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cook Medical
- 3-D Matrix
- EndoClot Plus
- Next Biomedical
- BioCer Entwicklungs
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemostatic Agents in Endoscopy Market Size (2021-2032)
2.1.2 Hemostatic Agents in Endoscopy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Hemostatic Agents in Endoscopy by Country/Region (2021, 2025 & 2032)
2.2 Hemostatic Agents in Endoscopy Segment by Type
2.2.1 Peptide Hydrogels
2.2.2 Mineral Hemostatic Powder
2.2.3 Other
2.2.4 Hemostatic Agents in Endoscopy Market Size by Type
2.2.4.1 Hemostatic Agents in Endoscopy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Hemostatic Agents in Endoscopy Market Size Market Share by Type (2021-2026)
2.3 Hemostatic Agents in Endoscopy Segment by Product
2.3.1 Self-assembling Type
2.3.2 Spray Type
2.3.3 Other
2.3.4 Hemostatic Agents in Endoscopy Market Size by Product
2.3.4.1 Hemostatic Agents in Endoscopy Market Size CAGR by Product (2021 VS 2025 VS 2032)
2.3.4.2 Global Hemostatic Agents in Endoscopy Market Size Market Share by Product (2021-2026)
2.4 Hemostatic Agents in Endoscopy Segment by Biodegradability
2.4.1 Absorbable / Biodegradable Agents
2.4.2 Temporary Non-Absorptive Barrier Systems
2.4.3 Hemostatic Agents in Endoscopy Market Size by Biodegradability
2.4.3.1 Hemostatic Agents in Endoscopy Market Size CAGR by Biodegradability (2021 VS 2025 VS 2032)
2.4.3.2 Global Hemostatic Agents in Endoscopy Market Size Market Share by Biodegradability (2021-2026)
2.5 Hemostatic Agents in Endoscopy Segment by Application
2.5.1 ESD
2.5.2 EMR
2.5.3 Other
2.5.4 Hemostatic Agents in Endoscopy Market Size by Application
2.5.4.1 Hemostatic Agents in Endoscopy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Hemostatic Agents in Endoscopy Market Size Market Share by Application (2021-2026)
3 HEMOSTATIC AGENTS IN ENDOSCOPY MARKET SIZE BY PLAYER
3.1 Hemostatic Agents in Endoscopy Market Size Market Share by Player
3.1.1 Global Hemostatic Agents in Endoscopy Revenue by Player (2021-2026)
3.1.2 Global Hemostatic Agents in Endoscopy Revenue Market Share by Player (2021-2026)
3.2 Global Hemostatic Agents in Endoscopy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HEMOSTATIC AGENTS IN ENDOSCOPY BY REGION
4.1 Hemostatic Agents in Endoscopy Market Size by Region (2021-2026)
4.2 Global Hemostatic Agents in Endoscopy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hemostatic Agents in Endoscopy Market Size Growth (2021-2026)
4.4 APAC Hemostatic Agents in Endoscopy Market Size Growth (2021-2026)
4.5 Europe Hemostatic Agents in Endoscopy Market Size Growth (2021-2026)
4.6 Middle East & Africa Hemostatic Agents in Endoscopy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Hemostatic Agents in Endoscopy Market Size by Country (2021-2026)
5.2 Americas Hemostatic Agents in Endoscopy Market Size by Type (2021-2026)
5.3 Americas Hemostatic Agents in Endoscopy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemostatic Agents in Endoscopy Market Size by Region (2021-2026)
6.2 APAC Hemostatic Agents in Endoscopy Market Size by Type (2021-2026)
6.3 APAC Hemostatic Agents in Endoscopy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hemostatic Agents in Endoscopy Market Size by Country (2021-2026)
7.2 Europe Hemostatic Agents in Endoscopy Market Size by Type (2021-2026)
7.3 Europe Hemostatic Agents in Endoscopy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemostatic Agents in Endoscopy by Region (2021-2026)
8.2 Middle East & Africa Hemostatic Agents in Endoscopy Market Size by Type (2021-2026)
8.3 Middle East & Africa Hemostatic Agents in Endoscopy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HEMOSTATIC AGENTS IN ENDOSCOPY MARKET FORECAST
10.1 Global Hemostatic Agents in Endoscopy Forecast by Region (2027-2032)
10.1.1 Global Hemostatic Agents in Endoscopy Forecast by Region (2027-2032)
10.1.2 Americas Hemostatic Agents in Endoscopy Forecast
10.1.3 APAC Hemostatic Agents in Endoscopy Forecast
10.1.4 Europe Hemostatic Agents in Endoscopy Forecast
10.1.5 Middle East & Africa Hemostatic Agents in Endoscopy Forecast
10.2 Americas Hemostatic Agents in Endoscopy Forecast by Country (2027-2032)
10.2.1 United States Market Hemostatic Agents in Endoscopy Forecast
10.2.2 Canada Market Hemostatic Agents in Endoscopy Forecast
10.2.3 Mexico Market Hemostatic Agents in Endoscopy Forecast
10.2.4 Brazil Market Hemostatic Agents in Endoscopy Forecast
10.3 APAC Hemostatic Agents in Endoscopy Forecast by Region (2027-2032)
10.3.1 China Hemostatic Agents in Endoscopy Market Forecast
10.3.2 Japan Market Hemostatic Agents in Endoscopy Forecast
10.3.3 Korea Market Hemostatic Agents in Endoscopy Forecast
10.3.4 Southeast Asia Market Hemostatic Agents in Endoscopy Forecast
10.3.5 India Market Hemostatic Agents in Endoscopy Forecast
10.3.6 Australia Market Hemostatic Agents in Endoscopy Forecast
10.4 Europe Hemostatic Agents in Endoscopy Forecast by Country (2027-2032)
10.4.1 Germany Market Hemostatic Agents in Endoscopy Forecast
10.4.2 France Market Hemostatic Agents in Endoscopy Forecast
10.4.3 UK Market Hemostatic Agents in Endoscopy Forecast
10.4.4 Italy Market Hemostatic Agents in Endoscopy Forecast
10.4.5 Russia Market Hemostatic Agents in Endoscopy Forecast
10.5 Middle East & Africa Hemostatic Agents in Endoscopy Forecast by Region (2027-2032)
10.5.1 Egypt Market Hemostatic Agents in Endoscopy Forecast
10.5.2 South Africa Market Hemostatic Agents in Endoscopy Forecast
10.5.3 Israel Market Hemostatic Agents in Endoscopy Forecast
10.5.4 Turkey Market Hemostatic Agents in Endoscopy Forecast
10.6 Global Hemostatic Agents in Endoscopy Forecast by Type (2027-2032)
10.7 Global Hemostatic Agents in Endoscopy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Hemostatic Agents in Endoscopy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Cook Medical
11.1.1 Cook Medical Company Information
11.1.2 Cook Medical Hemostatic Agents in Endoscopy Product Offered
11.1.3 Cook Medical Hemostatic Agents in Endoscopy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Cook Medical Main Business Overview
11.1.5 Cook Medical Latest Developments
11.2 3-D Matrix
11.2.1 3-D Matrix Company Information
11.2.2 3-D Matrix Hemostatic Agents in Endoscopy Product Offered
11.2.3 3-D Matrix Hemostatic Agents in Endoscopy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 3-D Matrix Main Business Overview
11.2.5 3-D Matrix Latest Developments
11.3 EndoClot Plus
11.3.1 EndoClot Plus Company Information
11.3.2 EndoClot Plus Hemostatic Agents in Endoscopy Product Offered
11.3.3 EndoClot Plus Hemostatic Agents in Endoscopy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 EndoClot Plus Main Business Overview
11.3.5 EndoClot Plus Latest Developments
11.4 Next Biomedical
11.4.1 Next Biomedical Company Information
11.4.2 Next Biomedical Hemostatic Agents in Endoscopy Product Offered
11.4.3 Next Biomedical Hemostatic Agents in Endoscopy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Next Biomedical Main Business Overview
11.4.5 Next Biomedical Latest Developments
11.5 BioCer Entwicklungs
11.5.1 BioCer Entwicklungs Company Information
11.5.2 BioCer Entwicklungs Hemostatic Agents in Endoscopy Product Offered
11.5.3 BioCer Entwicklungs Hemostatic Agents in Endoscopy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 BioCer Entwicklungs Main Business Overview
11.5.5 BioCer Entwicklungs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemostatic Agents in Endoscopy Market Size (2021-2032)
2.1.2 Hemostatic Agents in Endoscopy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Hemostatic Agents in Endoscopy by Country/Region (2021, 2025 & 2032)
2.2 Hemostatic Agents in Endoscopy Segment by Type
2.2.1 Peptide Hydrogels
2.2.2 Mineral Hemostatic Powder
2.2.3 Other
2.2.4 Hemostatic Agents in Endoscopy Market Size by Type
2.2.4.1 Hemostatic Agents in Endoscopy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Hemostatic Agents in Endoscopy Market Size Market Share by Type (2021-2026)
2.3 Hemostatic Agents in Endoscopy Segment by Product
2.3.1 Self-assembling Type
2.3.2 Spray Type
2.3.3 Other
2.3.4 Hemostatic Agents in Endoscopy Market Size by Product
2.3.4.1 Hemostatic Agents in Endoscopy Market Size CAGR by Product (2021 VS 2025 VS 2032)
2.3.4.2 Global Hemostatic Agents in Endoscopy Market Size Market Share by Product (2021-2026)
2.4 Hemostatic Agents in Endoscopy Segment by Biodegradability
2.4.1 Absorbable / Biodegradable Agents
2.4.2 Temporary Non-Absorptive Barrier Systems
2.4.3 Hemostatic Agents in Endoscopy Market Size by Biodegradability
2.4.3.1 Hemostatic Agents in Endoscopy Market Size CAGR by Biodegradability (2021 VS 2025 VS 2032)
2.4.3.2 Global Hemostatic Agents in Endoscopy Market Size Market Share by Biodegradability (2021-2026)
2.5 Hemostatic Agents in Endoscopy Segment by Application
2.5.1 ESD
2.5.2 EMR
2.5.3 Other
2.5.4 Hemostatic Agents in Endoscopy Market Size by Application
2.5.4.1 Hemostatic Agents in Endoscopy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Hemostatic Agents in Endoscopy Market Size Market Share by Application (2021-2026)
3 HEMOSTATIC AGENTS IN ENDOSCOPY MARKET SIZE BY PLAYER
3.1 Hemostatic Agents in Endoscopy Market Size Market Share by Player
3.1.1 Global Hemostatic Agents in Endoscopy Revenue by Player (2021-2026)
3.1.2 Global Hemostatic Agents in Endoscopy Revenue Market Share by Player (2021-2026)
3.2 Global Hemostatic Agents in Endoscopy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HEMOSTATIC AGENTS IN ENDOSCOPY BY REGION
4.1 Hemostatic Agents in Endoscopy Market Size by Region (2021-2026)
4.2 Global Hemostatic Agents in Endoscopy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hemostatic Agents in Endoscopy Market Size Growth (2021-2026)
4.4 APAC Hemostatic Agents in Endoscopy Market Size Growth (2021-2026)
4.5 Europe Hemostatic Agents in Endoscopy Market Size Growth (2021-2026)
4.6 Middle East & Africa Hemostatic Agents in Endoscopy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Hemostatic Agents in Endoscopy Market Size by Country (2021-2026)
5.2 Americas Hemostatic Agents in Endoscopy Market Size by Type (2021-2026)
5.3 Americas Hemostatic Agents in Endoscopy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemostatic Agents in Endoscopy Market Size by Region (2021-2026)
6.2 APAC Hemostatic Agents in Endoscopy Market Size by Type (2021-2026)
6.3 APAC Hemostatic Agents in Endoscopy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hemostatic Agents in Endoscopy Market Size by Country (2021-2026)
7.2 Europe Hemostatic Agents in Endoscopy Market Size by Type (2021-2026)
7.3 Europe Hemostatic Agents in Endoscopy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemostatic Agents in Endoscopy by Region (2021-2026)
8.2 Middle East & Africa Hemostatic Agents in Endoscopy Market Size by Type (2021-2026)
8.3 Middle East & Africa Hemostatic Agents in Endoscopy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HEMOSTATIC AGENTS IN ENDOSCOPY MARKET FORECAST
10.1 Global Hemostatic Agents in Endoscopy Forecast by Region (2027-2032)
10.1.1 Global Hemostatic Agents in Endoscopy Forecast by Region (2027-2032)
10.1.2 Americas Hemostatic Agents in Endoscopy Forecast
10.1.3 APAC Hemostatic Agents in Endoscopy Forecast
10.1.4 Europe Hemostatic Agents in Endoscopy Forecast
10.1.5 Middle East & Africa Hemostatic Agents in Endoscopy Forecast
10.2 Americas Hemostatic Agents in Endoscopy Forecast by Country (2027-2032)
10.2.1 United States Market Hemostatic Agents in Endoscopy Forecast
10.2.2 Canada Market Hemostatic Agents in Endoscopy Forecast
10.2.3 Mexico Market Hemostatic Agents in Endoscopy Forecast
10.2.4 Brazil Market Hemostatic Agents in Endoscopy Forecast
10.3 APAC Hemostatic Agents in Endoscopy Forecast by Region (2027-2032)
10.3.1 China Hemostatic Agents in Endoscopy Market Forecast
10.3.2 Japan Market Hemostatic Agents in Endoscopy Forecast
10.3.3 Korea Market Hemostatic Agents in Endoscopy Forecast
10.3.4 Southeast Asia Market Hemostatic Agents in Endoscopy Forecast
10.3.5 India Market Hemostatic Agents in Endoscopy Forecast
10.3.6 Australia Market Hemostatic Agents in Endoscopy Forecast
10.4 Europe Hemostatic Agents in Endoscopy Forecast by Country (2027-2032)
10.4.1 Germany Market Hemostatic Agents in Endoscopy Forecast
10.4.2 France Market Hemostatic Agents in Endoscopy Forecast
10.4.3 UK Market Hemostatic Agents in Endoscopy Forecast
10.4.4 Italy Market Hemostatic Agents in Endoscopy Forecast
10.4.5 Russia Market Hemostatic Agents in Endoscopy Forecast
10.5 Middle East & Africa Hemostatic Agents in Endoscopy Forecast by Region (2027-2032)
10.5.1 Egypt Market Hemostatic Agents in Endoscopy Forecast
10.5.2 South Africa Market Hemostatic Agents in Endoscopy Forecast
10.5.3 Israel Market Hemostatic Agents in Endoscopy Forecast
10.5.4 Turkey Market Hemostatic Agents in Endoscopy Forecast
10.6 Global Hemostatic Agents in Endoscopy Forecast by Type (2027-2032)
10.7 Global Hemostatic Agents in Endoscopy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Hemostatic Agents in Endoscopy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Cook Medical
11.1.1 Cook Medical Company Information
11.1.2 Cook Medical Hemostatic Agents in Endoscopy Product Offered
11.1.3 Cook Medical Hemostatic Agents in Endoscopy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Cook Medical Main Business Overview
11.1.5 Cook Medical Latest Developments
11.2 3-D Matrix
11.2.1 3-D Matrix Company Information
11.2.2 3-D Matrix Hemostatic Agents in Endoscopy Product Offered
11.2.3 3-D Matrix Hemostatic Agents in Endoscopy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 3-D Matrix Main Business Overview
11.2.5 3-D Matrix Latest Developments
11.3 EndoClot Plus
11.3.1 EndoClot Plus Company Information
11.3.2 EndoClot Plus Hemostatic Agents in Endoscopy Product Offered
11.3.3 EndoClot Plus Hemostatic Agents in Endoscopy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 EndoClot Plus Main Business Overview
11.3.5 EndoClot Plus Latest Developments
11.4 Next Biomedical
11.4.1 Next Biomedical Company Information
11.4.2 Next Biomedical Hemostatic Agents in Endoscopy Product Offered
11.4.3 Next Biomedical Hemostatic Agents in Endoscopy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Next Biomedical Main Business Overview
11.4.5 Next Biomedical Latest Developments
11.5 BioCer Entwicklungs
11.5.1 BioCer Entwicklungs Company Information
11.5.2 BioCer Entwicklungs Hemostatic Agents in Endoscopy Product Offered
11.5.3 BioCer Entwicklungs Hemostatic Agents in Endoscopy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 BioCer Entwicklungs Main Business Overview
11.5.5 BioCer Entwicklungs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hemostatic Agents in Endoscopy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Hemostatic Agents in Endoscopy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peptide Hydrogels
Table 4. Major Players of Mineral Hemostatic Powder
Table 5. Major Players of Other
Table 6. Hemostatic Agents in Endoscopy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Hemostatic Agents in Endoscopy Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Hemostatic Agents in Endoscopy Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Self-assembling Type
Table 10. Major Players of Spray Type
Table 11. Major Players of Other
Table 12. Hemostatic Agents in Endoscopy Market Size CAGR by Product (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Hemostatic Agents in Endoscopy Market Size by Product (2021-2026) & ($ millions)
Table 14. Global Hemostatic Agents in Endoscopy Market Size Market Share by Product (2021-2026)
Table 15. Major Players of Absorbable / Biodegradable Agents
Table 16. Major Players of Temporary Non-Absorptive Barrier Systems
Table 17. Hemostatic Agents in Endoscopy Market Size CAGR by Biodegradability (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Hemostatic Agents in Endoscopy Market Size by Biodegradability (2021-2026) & ($ millions)
Table 19. Global Hemostatic Agents in Endoscopy Market Size Market Share by Biodegradability (2021-2026)
Table 20. Hemostatic Agents in Endoscopy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Hemostatic Agents in Endoscopy Market Size by Application (2021-2026) & ($ millions)
Table 22. Global Hemostatic Agents in Endoscopy Market Size Market Share by Application (2021-2026)
Table 23. Global Hemostatic Agents in Endoscopy Revenue by Player (2021-2026) & ($ millions)
Table 24. Global Hemostatic Agents in Endoscopy Revenue Market Share by Player (2021-2026)
Table 25. Hemostatic Agents in Endoscopy Key Players Head office and Products Offered
Table 26. Hemostatic Agents in Endoscopy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Hemostatic Agents in Endoscopy Market Size by Region (2021-2026) & ($ millions)
Table 30. Global Hemostatic Agents in Endoscopy Market Size Market Share by Region (2021-2026)
Table 31. Global Hemostatic Agents in Endoscopy Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Hemostatic Agents in Endoscopy Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Hemostatic Agents in Endoscopy Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas Hemostatic Agents in Endoscopy Market Size Market Share by Country (2021-2026)
Table 35. Americas Hemostatic Agents in Endoscopy Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas Hemostatic Agents in Endoscopy Market Size Market Share by Type (2021-2026)
Table 37. Americas Hemostatic Agents in Endoscopy Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas Hemostatic Agents in Endoscopy Market Size Market Share by Application (2021-2026)
Table 39. APAC Hemostatic Agents in Endoscopy Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC Hemostatic Agents in Endoscopy Market Size Market Share by Region (2021-2026)
Table 41. APAC Hemostatic Agents in Endoscopy Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC Hemostatic Agents in Endoscopy Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe Hemostatic Agents in Endoscopy Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe Hemostatic Agents in Endoscopy Market Size Market Share by Country (2021-2026)
Table 45. Europe Hemostatic Agents in Endoscopy Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe Hemostatic Agents in Endoscopy Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa Hemostatic Agents in Endoscopy Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa Hemostatic Agents in Endoscopy Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa Hemostatic Agents in Endoscopy Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of Hemostatic Agents in Endoscopy
Table 51. Key Market Challenges & Risks of Hemostatic Agents in Endoscopy
Table 52. Key Industry Trends of Hemostatic Agents in Endoscopy
Table 53. Global Hemostatic Agents in Endoscopy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global Hemostatic Agents in Endoscopy Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global Hemostatic Agents in Endoscopy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global Hemostatic Agents in Endoscopy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Cook Medical Details, Company Type, Hemostatic Agents in Endoscopy Area Served and Its Competitors
Table 58. Cook Medical Hemostatic Agents in Endoscopy Product Offered
Table 59. Cook Medical Hemostatic Agents in Endoscopy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Cook Medical Main Business
Table 61. Cook Medical Latest Developments
Table 62. 3-D Matrix Details, Company Type, Hemostatic Agents in Endoscopy Area Served and Its Competitors
Table 63. 3-D Matrix Hemostatic Agents in Endoscopy Product Offered
Table 64. 3-D Matrix Hemostatic Agents in Endoscopy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. 3-D Matrix Main Business
Table 66. 3-D Matrix Latest Developments
Table 67. EndoClot Plus Details, Company Type, Hemostatic Agents in Endoscopy Area Served and Its Competitors
Table 68. EndoClot Plus Hemostatic Agents in Endoscopy Product Offered
Table 69. EndoClot Plus Hemostatic Agents in Endoscopy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. EndoClot Plus Main Business
Table 71. EndoClot Plus Latest Developments
Table 72. Next Biomedical Details, Company Type, Hemostatic Agents in Endoscopy Area Served and Its Competitors
Table 73. Next Biomedical Hemostatic Agents in Endoscopy Product Offered
Table 74. Next Biomedical Hemostatic Agents in Endoscopy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Next Biomedical Main Business
Table 76. Next Biomedical Latest Developments
Table 77. BioCer Entwicklungs Details, Company Type, Hemostatic Agents in Endoscopy Area Served and Its Competitors
Table 78. BioCer Entwicklungs Hemostatic Agents in Endoscopy Product Offered
Table 79. BioCer Entwicklungs Hemostatic Agents in Endoscopy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. BioCer Entwicklungs Main Business
Table 81. BioCer Entwicklungs Latest Developments
Table 1. Hemostatic Agents in Endoscopy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Hemostatic Agents in Endoscopy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peptide Hydrogels
Table 4. Major Players of Mineral Hemostatic Powder
Table 5. Major Players of Other
Table 6. Hemostatic Agents in Endoscopy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Hemostatic Agents in Endoscopy Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Hemostatic Agents in Endoscopy Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Self-assembling Type
Table 10. Major Players of Spray Type
Table 11. Major Players of Other
Table 12. Hemostatic Agents in Endoscopy Market Size CAGR by Product (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Hemostatic Agents in Endoscopy Market Size by Product (2021-2026) & ($ millions)
Table 14. Global Hemostatic Agents in Endoscopy Market Size Market Share by Product (2021-2026)
Table 15. Major Players of Absorbable / Biodegradable Agents
Table 16. Major Players of Temporary Non-Absorptive Barrier Systems
Table 17. Hemostatic Agents in Endoscopy Market Size CAGR by Biodegradability (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Hemostatic Agents in Endoscopy Market Size by Biodegradability (2021-2026) & ($ millions)
Table 19. Global Hemostatic Agents in Endoscopy Market Size Market Share by Biodegradability (2021-2026)
Table 20. Hemostatic Agents in Endoscopy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Hemostatic Agents in Endoscopy Market Size by Application (2021-2026) & ($ millions)
Table 22. Global Hemostatic Agents in Endoscopy Market Size Market Share by Application (2021-2026)
Table 23. Global Hemostatic Agents in Endoscopy Revenue by Player (2021-2026) & ($ millions)
Table 24. Global Hemostatic Agents in Endoscopy Revenue Market Share by Player (2021-2026)
Table 25. Hemostatic Agents in Endoscopy Key Players Head office and Products Offered
Table 26. Hemostatic Agents in Endoscopy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Hemostatic Agents in Endoscopy Market Size by Region (2021-2026) & ($ millions)
Table 30. Global Hemostatic Agents in Endoscopy Market Size Market Share by Region (2021-2026)
Table 31. Global Hemostatic Agents in Endoscopy Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Hemostatic Agents in Endoscopy Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Hemostatic Agents in Endoscopy Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas Hemostatic Agents in Endoscopy Market Size Market Share by Country (2021-2026)
Table 35. Americas Hemostatic Agents in Endoscopy Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas Hemostatic Agents in Endoscopy Market Size Market Share by Type (2021-2026)
Table 37. Americas Hemostatic Agents in Endoscopy Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas Hemostatic Agents in Endoscopy Market Size Market Share by Application (2021-2026)
Table 39. APAC Hemostatic Agents in Endoscopy Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC Hemostatic Agents in Endoscopy Market Size Market Share by Region (2021-2026)
Table 41. APAC Hemostatic Agents in Endoscopy Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC Hemostatic Agents in Endoscopy Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe Hemostatic Agents in Endoscopy Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe Hemostatic Agents in Endoscopy Market Size Market Share by Country (2021-2026)
Table 45. Europe Hemostatic Agents in Endoscopy Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe Hemostatic Agents in Endoscopy Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa Hemostatic Agents in Endoscopy Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa Hemostatic Agents in Endoscopy Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa Hemostatic Agents in Endoscopy Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of Hemostatic Agents in Endoscopy
Table 51. Key Market Challenges & Risks of Hemostatic Agents in Endoscopy
Table 52. Key Industry Trends of Hemostatic Agents in Endoscopy
Table 53. Global Hemostatic Agents in Endoscopy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global Hemostatic Agents in Endoscopy Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global Hemostatic Agents in Endoscopy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global Hemostatic Agents in Endoscopy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Cook Medical Details, Company Type, Hemostatic Agents in Endoscopy Area Served and Its Competitors
Table 58. Cook Medical Hemostatic Agents in Endoscopy Product Offered
Table 59. Cook Medical Hemostatic Agents in Endoscopy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Cook Medical Main Business
Table 61. Cook Medical Latest Developments
Table 62. 3-D Matrix Details, Company Type, Hemostatic Agents in Endoscopy Area Served and Its Competitors
Table 63. 3-D Matrix Hemostatic Agents in Endoscopy Product Offered
Table 64. 3-D Matrix Hemostatic Agents in Endoscopy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. 3-D Matrix Main Business
Table 66. 3-D Matrix Latest Developments
Table 67. EndoClot Plus Details, Company Type, Hemostatic Agents in Endoscopy Area Served and Its Competitors
Table 68. EndoClot Plus Hemostatic Agents in Endoscopy Product Offered
Table 69. EndoClot Plus Hemostatic Agents in Endoscopy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. EndoClot Plus Main Business
Table 71. EndoClot Plus Latest Developments
Table 72. Next Biomedical Details, Company Type, Hemostatic Agents in Endoscopy Area Served and Its Competitors
Table 73. Next Biomedical Hemostatic Agents in Endoscopy Product Offered
Table 74. Next Biomedical Hemostatic Agents in Endoscopy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Next Biomedical Main Business
Table 76. Next Biomedical Latest Developments
Table 77. BioCer Entwicklungs Details, Company Type, Hemostatic Agents in Endoscopy Area Served and Its Competitors
Table 78. BioCer Entwicklungs Hemostatic Agents in Endoscopy Product Offered
Table 79. BioCer Entwicklungs Hemostatic Agents in Endoscopy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. BioCer Entwicklungs Main Business
Table 81. BioCer Entwicklungs Latest Developments
LIST OF FIGURES
Figure 1. Hemostatic Agents in Endoscopy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hemostatic Agents in Endoscopy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Hemostatic Agents in Endoscopy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Hemostatic Agents in Endoscopy Sales Market Share by Country/Region (2025)
Figure 8. Hemostatic Agents in Endoscopy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Hemostatic Agents in Endoscopy Market Size Market Share by Type in 2025
Figure 10. Global Hemostatic Agents in Endoscopy Market Size Market Share by Product in 2025
Figure 11. Global Hemostatic Agents in Endoscopy Market Size Market Share by Biodegradability in 2025
Figure 12. Hemostatic Agents in Endoscopy in ESD
Figure 13. Global Hemostatic Agents in Endoscopy Market: ESD (2021-2026) & ($ millions)
Figure 14. Hemostatic Agents in Endoscopy in EMR
Figure 15. Global Hemostatic Agents in Endoscopy Market: EMR (2021-2026) & ($ millions)
Figure 16. Hemostatic Agents in Endoscopy in Other
Figure 17. Global Hemostatic Agents in Endoscopy Market: Other (2021-2026) & ($ millions)
Figure 18. Global Hemostatic Agents in Endoscopy Market Size Market Share by Application in 2025
Figure 19. Global Hemostatic Agents in Endoscopy Revenue Market Share by Player in 2025
Figure 20. Global Hemostatic Agents in Endoscopy Market Size Market Share by Region (2021-2026)
Figure 21. Americas Hemostatic Agents in Endoscopy Market Size 2021-2026 ($ millions)
Figure 22. APAC Hemostatic Agents in Endoscopy Market Size 2021-2026 ($ millions)
Figure 23. Europe Hemostatic Agents in Endoscopy Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Hemostatic Agents in Endoscopy Market Size 2021-2026 ($ millions)
Figure 25. Americas Hemostatic Agents in Endoscopy Value Market Share by Country in 2025
Figure 26. United States Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Hemostatic Agents in Endoscopy Market Size Market Share by Region in 2025
Figure 31. APAC Hemostatic Agents in Endoscopy Market Size Market Share by Type (2021-2026)
Figure 32. APAC Hemostatic Agents in Endoscopy Market Size Market Share by Application (2021-2026)
Figure 33. China Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 37. India Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Hemostatic Agents in Endoscopy Market Size Market Share by Country in 2025
Figure 40. Europe Hemostatic Agents in Endoscopy Market Size Market Share by Type (2021-2026)
Figure 41. Europe Hemostatic Agents in Endoscopy Market Size Market Share by Application (2021-2026)
Figure 42. Germany Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 43. France Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Hemostatic Agents in Endoscopy Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Hemostatic Agents in Endoscopy Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Hemostatic Agents in Endoscopy Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 56. APAC Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 57. Europe Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 59. United States Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 60. Canada Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 61. Mexico Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 62. Brazil Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 63. China Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 64. Japan Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 65. Korea Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 67. India Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 68. Australia Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 69. Germany Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 70. France Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 71. UK Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 72. Italy Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 73. Russia Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 74. Egypt Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 75. South Africa Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 76. Israel Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 77. Turkey Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 78. Global Hemostatic Agents in Endoscopy Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Hemostatic Agents in Endoscopy Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 1. Hemostatic Agents in Endoscopy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hemostatic Agents in Endoscopy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Hemostatic Agents in Endoscopy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Hemostatic Agents in Endoscopy Sales Market Share by Country/Region (2025)
Figure 8. Hemostatic Agents in Endoscopy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Hemostatic Agents in Endoscopy Market Size Market Share by Type in 2025
Figure 10. Global Hemostatic Agents in Endoscopy Market Size Market Share by Product in 2025
Figure 11. Global Hemostatic Agents in Endoscopy Market Size Market Share by Biodegradability in 2025
Figure 12. Hemostatic Agents in Endoscopy in ESD
Figure 13. Global Hemostatic Agents in Endoscopy Market: ESD (2021-2026) & ($ millions)
Figure 14. Hemostatic Agents in Endoscopy in EMR
Figure 15. Global Hemostatic Agents in Endoscopy Market: EMR (2021-2026) & ($ millions)
Figure 16. Hemostatic Agents in Endoscopy in Other
Figure 17. Global Hemostatic Agents in Endoscopy Market: Other (2021-2026) & ($ millions)
Figure 18. Global Hemostatic Agents in Endoscopy Market Size Market Share by Application in 2025
Figure 19. Global Hemostatic Agents in Endoscopy Revenue Market Share by Player in 2025
Figure 20. Global Hemostatic Agents in Endoscopy Market Size Market Share by Region (2021-2026)
Figure 21. Americas Hemostatic Agents in Endoscopy Market Size 2021-2026 ($ millions)
Figure 22. APAC Hemostatic Agents in Endoscopy Market Size 2021-2026 ($ millions)
Figure 23. Europe Hemostatic Agents in Endoscopy Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Hemostatic Agents in Endoscopy Market Size 2021-2026 ($ millions)
Figure 25. Americas Hemostatic Agents in Endoscopy Value Market Share by Country in 2025
Figure 26. United States Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Hemostatic Agents in Endoscopy Market Size Market Share by Region in 2025
Figure 31. APAC Hemostatic Agents in Endoscopy Market Size Market Share by Type (2021-2026)
Figure 32. APAC Hemostatic Agents in Endoscopy Market Size Market Share by Application (2021-2026)
Figure 33. China Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 37. India Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Hemostatic Agents in Endoscopy Market Size Market Share by Country in 2025
Figure 40. Europe Hemostatic Agents in Endoscopy Market Size Market Share by Type (2021-2026)
Figure 41. Europe Hemostatic Agents in Endoscopy Market Size Market Share by Application (2021-2026)
Figure 42. Germany Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 43. France Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Hemostatic Agents in Endoscopy Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Hemostatic Agents in Endoscopy Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Hemostatic Agents in Endoscopy Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Hemostatic Agents in Endoscopy Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 56. APAC Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 57. Europe Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 59. United States Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 60. Canada Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 61. Mexico Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 62. Brazil Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 63. China Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 64. Japan Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 65. Korea Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 67. India Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 68. Australia Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 69. Germany Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 70. France Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 71. UK Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 72. Italy Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 73. Russia Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 74. Egypt Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 75. South Africa Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 76. Israel Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 77. Turkey Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
Figure 78. Global Hemostatic Agents in Endoscopy Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Hemostatic Agents in Endoscopy Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Hemostatic Agents in Endoscopy Market Size 2027-2032 ($ millions)
